US clears new treatments for MS, atopic dermatitis
admin 29th March 2017 Uncategorised 0Roche/Genentech’s Ocrevus has been approved by the US Food and Drug Administration to treat both relapsing and primary progressive forms of multiple sclerosis, while Sanofi’s Dupixent was cleared for certain patients with moderate-to-severe atopic dermatitis.
More: US clears new treatments for MS, atopic dermatitis
Source: News